These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6114963)

  • 1. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant somatostatinoma: clinical features and metabolic studies.
    Axelrod L; Bush MA; Hirsch HJ; Loo SW
    J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of plasma glucagon in experimental fasting and somatostatin test in islet cell tumors].
    Drost H; Berger M; Berchtold P; Wiegelmann W; Zimmermann H; Gries FA
    Med Welt; 1976 Jul; 27(28):1381-3. PubMed ID: 183080
    [No Abstract]   [Full Text] [Related]  

  • 5. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic function tests].
    Abe M; Ikeda Y; Yaginuma M; Shimizu N
    Nihon Rinsho; 1969 Feb; 27(2):291-300. PubMed ID: 4306418
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Somatostatin and insulinoma.
    Christensen SE; Hansen AP; Lundbaek K; Orskov H; Seyer-Hansen K
    Lancet; 1975 Jun; 1(7922):1426. PubMed ID: 49589
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucagonoma syndrome with a normal blood glucose curve].
    González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
    Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
    Valverde I; Lemon HM; Kessinger A; Unger RH
    J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma glucagon in insulinoma.
    Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
    Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate.
    Lins PE; Efendić S
    Diabetes; 1979 Mar; 28(3):190-5. PubMed ID: 221293
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose intolerance in a patient with insulinoma. Report of a case.
    Christiansen J; Munkgaard S
    Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
    [No Abstract]   [Full Text] [Related]  

  • 13. A malignant insulinoma transformed into a glucagonoma syndrome.
    Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
    Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
    Luyckx AS; Lefebvre PJ
    Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 18. The metabolic effects of chronic hyperglucagonaemia.
    Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
    Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
    N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
    [No Abstract]   [Full Text] [Related]  

  • 20. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.